Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study

Federica Magnè; Maria Cellerino; Elisa Balletto; Kenda Aluan; Matilde Inglese; Malgorzata Mikulska; Matteo Bassetti

doi:10.1177/13524585221103787

Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study

Federica Magnè, Maria Cellerino, Elisa Balletto, Kenda Aluan, Matilde Inglese, Malgorzata Mikulska, Matteo Bassetti

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	481-482
Number of pages	2
Journal	Multiple Sclerosis Journal
Volume	29
Issue number	3
DOIs	https://doi.org/10.1177/13524585221103787
State	Published - Mar 2023
Externally published	Yes

Access to Document

10.1177/13524585221103787

Cite this

@article{f9e1a853a5214e8e80e74a942be375cc,

title = "Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study",

author = "Federica Magn{\`e} and Maria Cellerino and Elisa Balletto and Kenda Aluan and Matilde Inglese and Malgorzata Mikulska and Matteo Bassetti",

note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was developed within the framework of the DINOGMI Department of Excellence of MIUR 2018-2022 (legge 232 del 2016). This work was supported by grants from Italian Ministry of Health (Rete delle Neuroscienze e della Neuroriabilitazione). ",

year = "2023",

month = mar,

doi = "10.1177/13524585221103787",

language = "English",

volume = "29",

pages = "481--482",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "3",

}

TY - JOUR

T1 - Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis

T2 - An observational study

AU - Magnè, Federica

AU - Cellerino, Maria

AU - Balletto, Elisa

AU - Aluan, Kenda

AU - Inglese, Matilde

AU - Mikulska, Malgorzata

AU - Bassetti, Matteo

N1 - Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was developed within the framework of the DINOGMI Department of Excellence of MIUR 2018-2022 (legge 232 del 2016). This work was supported by grants from Italian Ministry of Health (Rete delle Neuroscienze e della Neuroriabilitazione).

PY - 2023/3

Y1 - 2023/3

UR - http://www.scopus.com/inward/record.url?scp=85133376888&partnerID=8YFLogxK

U2 - 10.1177/13524585221103787

DO - 10.1177/13524585221103787

M3 - Letter

C2 - 35762136

AN - SCOPUS:85133376888

SN - 1352-4585

VL - 29

SP - 481

EP - 482

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 3

ER -